- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
1 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$3.3b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$5.24
7D
45.6%
1Y
315.9%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
New
CRON
CA$3.84
7D
2.4%
1Y
54.8%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.81
7D
13.7%
1Y
47.1%
Trulieve Cannabis
Market Cap: CA$1.8b
Operates as a cannabis retailer in the United States.
TRUL
CA$11.15
7D
20.5%
1Y
107.6%